Patents by Inventor Jordan Bajor

Jordan Bajor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925512
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: March 12, 2024
    Assignee: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Patent number: 11826207
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: November 28, 2023
    Assignee: Gynesonics, Inc
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Publication number: 20220265381
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: May 11, 2022
    Publication date: August 25, 2022
    Inventors: Michael MUNROW, Jordan BAJOR, Malcolm G. MUNRO
  • Publication number: 20210338365
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: July 14, 2021
    Publication date: November 4, 2021
    Inventors: Michael MUNROW, Jordan BAJOR, Malcolm G. MUNRO
  • Patent number: 11096760
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: August 24, 2021
    Assignee: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Patent number: 11096761
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: August 24, 2021
    Assignee: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Publication number: 20210038341
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: September 22, 2020
    Publication date: February 11, 2021
    Inventors: Michael MUNROW, Jordan BAJOR, Malcolm G. MUNRO
  • Publication number: 20210000565
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: September 22, 2020
    Publication date: January 7, 2021
    Inventors: Michael MUNROW, Jordan BAJOR, Malcolm G. MUNRO
  • Publication number: 20200229892
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: April 6, 2020
    Publication date: July 23, 2020
    Inventors: Michael MUNROW, Jordan BAJOR, Malcolm G. MUNRO
  • Publication number: 20170245838
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: May 15, 2017
    Publication date: August 31, 2017
    Inventors: Michael MUNROW, Jordan BAJOR, Malcom G. MUNRO
  • Publication number: 20170245891
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: May 17, 2017
    Publication date: August 31, 2017
    Inventors: Michael MUNROW, Jordan BAJOR, Malcom G. MUNRO
  • Publication number: 20120316440
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: August 20, 2012
    Publication date: December 13, 2012
    Applicant: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Patent number: 8298145
    Abstract: Uterine fibroids and other tissue masses are treated using an electrode or other treatment element introduced into a potential or peri-capsular space surrounding the fibroid under ultrasonic imaging. A therapy is delivered into the potential space by the treatment element in order to reduce or eliminate blood supply to the fibroid or other tissue mass.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: October 30, 2012
    Assignee: Gynesonics, Inc.
    Inventors: Robert K. Deckman, Craig Gerbi, Michael Munrow, Jordan Bajor, Jessica Grossman
  • Patent number: 8262577
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: September 11, 2012
    Assignee: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Publication number: 20120078134
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: November 30, 2011
    Publication date: March 29, 2012
    Applicant: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Patent number: 8088072
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: January 3, 2012
    Assignee: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Publication number: 20090287081
    Abstract: Submucosal fibroids are selectively treated by introducing a visualization and ablation instrument into a patient's uterus. Many or all of the fibroids are visualized, and the submucosal fibroids are identified. The identified submucosal fibroids are then selectively targeted, typically using a needle on the visualization and ablation instrument. In this way, the patients can be treated for menorrhagia without prolonging the time to treat intramural and subserosal fibroids which typically aren't responsible for menorrhagia.
    Type: Application
    Filed: April 15, 2009
    Publication date: November 19, 2009
    Applicant: Gynesonics , Inc
    Inventors: Jessica GROSSMAN, Teodoro BELLEZA, Graig GERBI, Michael MUNROW, Jordan BAJOR
  • Publication number: 20090099544
    Abstract: Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 16, 2009
    Applicant: Gynesonics, Inc.
    Inventors: Michael Munrow, Jordan Bajor, Malcolm G. Munro
  • Publication number: 20080108945
    Abstract: An access tube is used for accessing an anatomic space, such as a pericardial space between the parietal and visceral pericardia. The access tube is advanced against the parietal pericardium and an anchor structure thereon embedded into the parietal pericardium. The access tube can then be used to separate the parietal and visceral pericardia and enlarge the pericardial space. After such enlargement, a needle or other access device can be introduced through the access tube into the pericardial space to provide access for a wide variety of purposes, including aspiration, infusion, and guidewire placement.
    Type: Application
    Filed: October 16, 2007
    Publication date: May 8, 2008
    Inventors: Aaron Kaplan, Jordan Bajor, Nubar Manoukian
  • Publication number: 20080033493
    Abstract: Uterine fibroids and other tissue masses are treated using an electrode or other treatment element introduced into a potential or peri-capsular space surrounding the fibroid under ultrasonic imaging. A therapy is delivered into the potential space by the treatment element in order to reduce or eliminate blood supply to the fibroid or other tissue mass.
    Type: Application
    Filed: July 10, 2007
    Publication date: February 7, 2008
    Applicant: Gynesonics, Inc.
    Inventors: Robert K. Deckman, Craig Gerbi, Michael Munrow, Jordan Bajor, Jessica Grossman